Topical tranexamic acid in total knee replacement: A systematic review and meta-analysis

Knee

Volumn 20, Issue 5, 2013, Pages 300-309

  Panteli, Michalis ^a   Papakostidis, Costas ^b   Dahabreh, Ziad ^c   Giannoudis, Peter V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^c Sydney Orthopaedic Foot and Ankle Research Institute   (Australia)

Author keywords

Antifibrinolytics; Cyklokapron; Intra articular; Topical tranexamic acid; Total knee arthroplasty

Indexed keywords

CARBAZOCHROME; DALTEPARIN; ENOXAPARIN; HEMOGLOBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; SODIUM CHLORIDE; TRANEXAMIC ACID;

BLOOD TRANSFUSION; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EFFECT SIZE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LUNG EMBOLISM; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

ANTIFIBRINOLYTICS; CYKLOKAPRON; INTRA-ARTICULAR; TOPICAL TRANEXAMIC ACID; TOTAL KNEE ARTHROPLASTY;

ADMINISTRATION, TOPICAL; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; DRAINAGE; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84882578922     PISSN: 09680160     EISSN: 18735800     Source Type: Journal    
DOI: 10.1016/j.knee.2013.05.014     Document Type: Review

References (56)

1. Listed NA National Joint Registry for England and Wales. Summary of annual statistics (England and Wales) 2011.
2. Ferraris V.A., Brown J.R., Despotis G.J., Hammon J.W., Reece T.B., Saha S.P., et al. 2011 Update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011, 91(3):944-982.
3. Neilipovitz D.T. Tranexamic acid for major spinal surgery. Eur Spine J 2004, 13(1):S62-S65.
4. Klenerman L., Chakrabarti R., Mackie I., Brozovic M., Stirling Y. Changes in haemostatic system after application of a tourniquet. Lancet 1977, 309(8019):970-972.
5. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006, 105(1):198-208.
6. Ker K., Edwards P., Perel P., Shakur H., Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012, 344:e3054.
7. Tenholder M., Cushner F.D. Intraoperative blood management in joint replacement surgery. Orthopedics 2004, 27(6 Suppl.):s663-s668.
8. Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 2008, 90(9):1128-1136.
9. Madjdpour C., Spahn D.R. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 2005, 95(1):33-42.
10. Abrishami A., Chung F., Wong J. Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. Can J Anaesth 2009, 56(3):202-212.
11. Tobias J.D. Strategies for minimizing blood loss in orthopedic surgery. Semin Hematol 2004, 41(1 Suppl. 1):S145-S156.
12. Meert K.L., Kannan S., Mooney J.F. Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine 2002, 27(19):2137-2142.
13. Cole J.W., Murray D.J., Snider R.J., Bassett G.S., Bridwell K.H., Lenke L.G. Aprotinin reduces blood loss during spinal surgery in children. Spine 2003, 28(21):2482-2485.
14. Thompson G.H., Florentino-Pineda I., Poe-Kochert C. The role of amicar in decreasing perioperative blood loss in idiopathic scoliosis. Spine 2005, 30(17 Suppl.):S94-S99.
15. Copley L.A., Richards B.S., Safavi F.Z., Newton P.O. Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery. Spine 1999, 24(3):219-222. [discussion 23-4].
16. Murray D.J., Forbes R.B., Titone M.B., Weinstein S.L. Transfusion management in pediatric and adolescent scoliosis surgery Efficacy of autologous blood. Spine 1997, 22(23):2735-2740.
17. Bierbaum B.E., Callaghan J.J., Galante J.O., Rubash H.E., Tooms R.E., Welch R.B. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81(1):2-10.
18. Moonen A.F., Neal T.D., Pilot P. Peri-operative blood management in elective orthopaedic surgery. A critical review of the literature. Injury 2006, 37(Suppl. 5):S11-S16.
19. Goodnough L.T., Brecher M.E., Kanter M.H., AuBuchon J.P. Transfusion medicine. Second of two parts-blood conservation. N Engl J Med 1999, 340(7):525-533.
20. Goodnough L.T., Monk T.G., Despotis G.J., Merkel K. A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox Sang 1999, 77(1):11-16.
21. Sabatini L., Trecci A., Imarisio D., Uslenghi M.D., Bianco G., Scagnelli R. Fibrin tissue adhesive reduces postoperative blood loss in total knee arthroplasty. J Orthop Traumatol 2012, 13(3):145-151.
22. Kagoma Y.K., Crowther M.A., Douketis J., Bhandari M., Eikelboom J., Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009, 123(5):687-696.
23. Zufferey P., Merquiol F., Laporte S., Decousus H., Mismetti P., Auboyer C., et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?. Anesthesiology 2006, 105(5):1034-1046.
24. Pfizer Product information. Cyklokapron (Tranexamic Acid) 2011.
25. Sharma V., Fan J., Jerath A., Pang K.S., Bojko B., Pawliszyn J., et al. Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass. Anaesthesia 2012, 67(11):1242-1250.
26. Hardy J.F., Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 1992, 39(4):353-365.
27. Horrow J.C., Van Riper D.F., Strong M.D., Grunewald K.E., Parmet J.L. The dose-response relationship of tranexamic acid. Anesthesiology 1995, 82(2):383-392.
28. Koster A., Schirmer U. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era. Curr Opin Anaesthesiol 2011, 24(1):92-97.
29. Ngaage D.L., Bland J.M. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. Eur J Cardiothorac Surg 2010, 37(6):1375-1383.
30. Raveendran R., Wong J. Tranexamic acid reduces blood transfusion in surgical patients while its effects on thromboembolic events and mortality are uncertain. Evid Based Med 2012, [Epub ahead of print].
31. Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol Suppl 1987, 137:22-25. [Suppl.].
32. Sukeik M., Alshryda S., Haddad F.S., Mason J.M. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011, 93(1):39-46.
33. Gill J.B., Chin Y., Levin A., Feng D. The use of antifibrinolytic agents in spine surgery. A meta-analysis. J Bone Joint Surg Am 2008, 90(11):2399-2407.
34. Ho K.M., Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003, 31(5):529-537.
35. Higgins J.P., Green S. Cochrane handbook for systematic reviews of interventions 2011.
36. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009, 62(10):1006-1012.
37. Foley N.C., Bhogal S.K., Teasell R.W., Bureau Y., Speechley M.R. Estimates of quality and reliability with the physiotherapy evidence-based database scale to assess the methodology of randomized controlled trials of pharmacological and nonpharmacological interventions. Phys Ther 2006, 86(6):817-824.
38. Verhagen A.P., de Vet H.C., de Bie R.A., Kessels A.G., Boers M., Bouter L.M., et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998, 51(12):1235-1241.
39. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
40. Cochran W. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
41. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
42. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127(9):820-826.
43. Egger M.S.G., Altman D.G. Systematic reviews in health care meta-analysis in context 2004, BMJ Books, London.
44. Abrishami A. Timing and volume of topical tranexamic acid administration for postoperative blood loss in total knee arthroplasty. Can J Anesth 2010, 51(Suppl. 1):S142-S143.
45. Wong J., Abrishami A., El Beheiry H., Mahomed N.N., Roderick Davey J., Gandhi R., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010, 92(15):2503-2513.
46. Maniar R.N., Kumar G., Singhi T., Nayak R.M., Maniar P.R. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012, 470(9):2605-2612.
47. Sa-Ngasoongsong P., Channoom T., Kawinwonggowit V., Woratanarat P., Chanplakorn P., Wibulpolprasert B., et al. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Orthop Rev(Pavia) 2011, 3(2):e12.
48. Roy S.P., Tanki U.F., Dutta A., Jain S.K., Nagi O.N. Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2012, 20(12):2494-2501.
49. Ishida K., Tsumura N., Kitagawa A., Hamamura S., Fukuda K., Dogaki Y., et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011, 35(11):1639-1645.
50. Onodera T., Majima T., Sawaguchi N., Kasahara Y., Ishigaki T., Minami A. Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. J Arthroplasty 2012, 27(1):105-108.
51. Kocher M.S., Zurakowski D. Clinical epidemiology and biostatistics: a primer for orthopaedic surgeons. J Bone Joint Surg Am 2004, 86-A(3):607-620.
52. Benoni G., Lethagen S., Fredin H. The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty. Thromb Res 1997, 85(3):195-206.
53. Alshryda S., Sarda P., Sukeik M., Nargol A., Blenkinsopp J., Mason J.M. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011, 93(12):1577-1585.
54. Eubanks J.D. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 2010, 18(3):132-138.
55. Ipema H.J., Tanzi M.G. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother 2012, 46(1):97-107.
56. Yang Z.G., Chen W.P., Wu L.D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012, 94(13):1153-1159.